UK Adds New Sickle Cell Therapy Adakveo to National Health Service

UK Adds New Sickle Cell Therapy Adakveo to National Health Service

308487

UK Adds New Sickle Cell Therapy Adakveo to National Health Service

A new treatment, called Adakveo (crizanlizumab), is now available to treat sickle cell disease (SCD) patients — the first time in decades that a new therapy for the disease has been made accessible — through the United Kingdom’s National Health Service (NHS), according to the U.K. Sickle Cell Society. Adakveo will be available in England and Wales to eligible patients, 16 years and older, to help prevent recurrent sickle cell crises (pain episodes). “This new…

You must be logged in to read/download the full post.